Search Results - I. N. Dyakov
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
Pharmacoeconomic characteristics of agonists of receptors for glucagon-like peptide-1 and medicines on their base by I. N. Dyakov, S. K. Zyryanov
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Economic perspectives for effective control of diabetes mellitus type 2 with fixed combination of basal insulin analog and GLP-1 agonist by S. K. Zyryanov, I. N. Dyakov
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy by S. K. Zyryanov, I. N. Dyakov
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Health technology assessement of the fxed combination of insulin glargine 100 UI/ml and lixisenatide in the treatment intensifcation of diabetes mellitus type 2 by S. К. Zyryanov, I. N. Dyakov
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Clinical and economic efficiency of treatment with dapagliflozin of patients with type 2 diabetes mellitus in Russian health care conditions by S. K. Zyryanov, I. N. Dyakov
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in th... by S. К. Zyryanov, I. N. Dyakov
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small... by S. К. Zyryanov, I. N. Dyakov
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
8
Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy by S. K. Zyryanov, I. N. Dyakov
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
9
The pharmacoeconomic comparison of the fixed insulin glargine and lixisenatide combination with insulin degludec family in type 2 diabetes mellitus by I. N. Dyakov, S. K. Zyryanov
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
10
The economic side of an oral sugar lowering therapy intensification by glucagon-like peptidt-1 receptor agonists by S. K. Zyryanov, I. N. Dyakov
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
11
Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2 by I. N. Dyakov, S. K. Zyryanov
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
12
Economic expertise of alirocumab in standard lipid lowering therapy insusceptibility by S. K. Zyryanov, I. N. Dyakov
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
13
Pharmacoeconomic effectiveness of lenvatinib in patients with differentiated radioiodine-resistant thyroid cancer by S. K. Zyryanov, I. N. Dyakov
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
14
Pharmacoeconomics expediency of application of the combined preparation of Vezomni in comparison with a combination of Tamsulosin and Solifenacin in the form of monopreparations by S. K. Zyryanov, I. N. Dyakov
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
15
Pharmacoeconomic comparison of the second generation insulin analogs and insulins on their base by I. N. Dyakov, S. K. Zyryanov
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
16
Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder by I. N. Dyakov, G. R. Kasyan
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
17
Pharmacoeconomic feasibility of using the drug Hemangiol (propranolol, oral solution) in the treatment of proliferating infantile hemangioma requiring systemic therapy by I. N. Dyakov, S. R. Varfolomeеva
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
18
Modeling of the impact of biological drugs in the economic burden of severe asthma by S. K. Zyryanov, I. N. Dyakov, O. I. Karpov
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
19
harmacoeconomic feasibility of using the drug upadacitinib in patients with rheumatoid arthritis in the healthcare system of the Russian Federation by A. M. Lila, S. K. Zyryanov, I. N. Dyakov
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
20
Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price by D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book